Internal Medicine, Medical Oncology · Indianapolis, IN
NPI
1316903883
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
535 Barnhill Dr, Rt 473
Indianapolis, IN, 46202
Phone (317) 278-0054
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
238 services
Medicare patients, 2024
99
Average age 70
Drug cost, 2024
$2.4M
628 prescriptions
Company payments, 2025
$39.98
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nasser H Hanna was code 99214 (office e&m - established), 103 times for 47 patients. In total Nasser H Hanna billed 238 services in 12 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 103 | 47 | $67.47 | $6,949 |
| 99213 Office E&M - Established | Facility | 37 | 33 | $48.61 | $1,798 |
| 99442 Telephone Services | Facility | 28 | 15 | $46.69 | $1,307 |
| 99215 Office E&M - Established | Facility | 25 | 14 | $101.23 | $2,531 |
| 99205 Office E&M - New | Facility | 13 | 13 | $125.87 | $1,636 |
By year: 2022 $36K for 534 services; 2023 $19K for 309 services; 2024 $16K for 238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nasser H Hanna prescribed most often to Medicare patients was Alecensa (Alectinib Hcl), with 62 prescriptions and refills. In total Nasser H Hanna wrote 628 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alecensa Alectinib Hcl | 62 | 62 | Under 11 | $833K |
| Tagrisso Osimertinib Mesylate | 53 | 53 | Under 11 | $871K |
| Dexamethasone Generic | 40 | 40 | 13 | $471 |
| Prednisone Generic | 37 | 45 | Under 11 | $123 |
| Zolpidem Tartrate Generic | 36 | 36 | Under 11 | $142 |
| Gabapentin Generic | 24 | 26 | Under 11 | $406 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $329 |
| Hydrochlorothiazide Generic | 16 | 28 | Under 11 | $22.09 |
| Pravastatin Sodium Generic | 15 | 35 | Under 11 | $498 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $599 |
| Hydrocortisone Generic | 15 | 15 | Under 11 | $460 |
| Prochlorperazine Maleate Generic | 14 | 14 | 11 | $134 |
| Omeprazole Generic | 14 | 24 | Under 11 | $194 |
| Levothyroxine Sodium Generic | 13 | 29 | Under 11 | $149 |
| Lorbrena Lorlatinib | 13 | 13 | Under 11 | $264K |
Brand drugs: 187 claims; generic drugs: 441 claims; opioid claims: 80.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nasser H Hanna $39.98 ($39.98 in general payments such as food, travel and fees) from 4 companies. The largest payer was Daiichi Sankyo Inc. with $23.52.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.